SIC 2834 · Manufacturing
Pharmaceutical Preparations
OpenFilings tracks 194 companies that the SEC classifies under Standard Industrial Classification code 2834; the most recent filing among them is dated Oct 27, 2026. 193 of them report standardized annual figures in XBRL, shown in the revenue column.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. Not investment advice.
Companies in this industry
| # | Company | State | Latest filing | Revenue (latest FY) |
|---|---|---|---|---|
| 10 | LLY ELI LILLY & Co | IN | Oct 22, 2026 | $65.2BFY2025 |
| 17 | JNJ JOHNSON & JOHNSON | NJ | Oct 26, 2026 | $94.2BFY2025 |
| 20 | ABBV AbbVie Inc. | IL | Oct 23, 2026 | $61.2BFY2025 |
| 30 | MRK Merck & Co., Inc. | NJ | Oct 22, 2026 | $65.0BFY2025 |
| 39 | NVS NOVARTIS AG | Switzerland | Oct 27, 2026 | —FY2025 |
| 47 | AZN ASTRAZENECA PLC | — | Oct 27, 2026 | $58.7BFY2025 |
| 84 | ABT ABBOTT LABORATORIES | IL | Oct 21, 2026 | $44.3BFY2025 |
| 87 | NVO NOVO NORDISK A S | Denmark | Oct 26, 2026 | DKK 309.1BFY2025 |
| 88 | PFE PFIZER INC | NY | Oct 16, 2026 | $62.6BFY2025 |
| 118 | VRTX VERTEX PHARMACEUTICALS INC / MA | MA | Oct 22, 2026 | $12.0BFY2025 |
| 125 | BMY BRISTOL MYERS SQUIBB CO | NJ | Oct 5, 2026 | $48.2BFY2025 |
| 163 | GSK GSK plc | — | Oct 26, 2026 | GBP 32.7BFY2025 |
| 164 | SNY Sanofi | France | Oct 26, 2026 | —FY2025 |
| 201 | REGN REGENERON PHARMACEUTICALS, INC. | NY | Oct 15, 2026 | $14.3BFY2025 |
| 260 | TAK TAKEDA PHARMACEUTICAL CO LTD | Japan | Sep 15, 2026 | JPY 4.58TFY2025 |
| 332 | TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | — | Oct 8, 2026 | $17.3BFY2025 |
| 361 | ONC BeOne Medicines Ltd. | — | Oct 15, 2026 | $5.3BFY2025 |
| 403 | RPRX Royalty Pharma plc | NY | Oct 5, 2026 | $2.4BFY2025 |
| 429 | ZTS Zoetis Inc. | NJ | Oct 13, 2026 | $9.5BFY2025 |
| 453 | ALNY ALNYLAM PHARMACEUTICALS, INC. | MA | Oct 6, 2026 | $3.7BFY2025 |
| 493 | ROIV Roivant Sciences Ltd. | — | Oct 27, 2026 | $8.3MFY2026 |
| 518 | UTHR UNITED THERAPEUTICS Corp | MD | Oct 27, 2026 | $3.2BFY2025 |
| 526 | GMAB GENMAB A/S | Denmark | Oct 23, 2026 | —FY2024 |
| 579 | VTRS Viatris Inc | PA | Oct 8, 2026 | $14.3BFY2025 |
| 591 | INSM INSMED Inc | NJ | Oct 20, 2026 | $606.4MFY2025 |
| 675 | ASND Ascendis Pharma A/S | — | Oct 26, 2026 | EUR 720.1MFY2025 |
| 741 | JAZZ Jazz Pharmaceuticals plc | — | Oct 26, 2026 | $4.3BFY2025 |
| 766 | BBIO BridgeBio Pharma, Inc. | CA | Oct 27, 2026 | $502.1MFY2025 |
| 802 | SMMT Summit Therapeutics Inc. | FL | Oct 19, 2026 | —FY2025 |
| 817 | CORT CORCEPT THERAPEUTICS INC | CA | Oct 27, 2026 | $761.4MFY2025 |
| 849 | ELAN Elanco Animal Health Inc | IN | Oct 20, 2026 | $4.7BFY2025 |
| 862 | RDY DR REDDYS LABORATORIES LTD | — | Oct 26, 2026 | INR 325.5BFY2025 |
| 868 | BMRN BIOMARIN PHARMACEUTICAL INC | CA | Oct 6, 2026 | $3.2BFY2025 |
| 885 | MDGL MADRIGAL PHARMACEUTICALS, INC. | PA | Sep 28, 2026 | $958.4MFY2025 |
| 964 | PTGX Protagonist Therapeutics, Inc | CA | Oct 27, 2026 | $46.0MFY2025 |
| 983 | CYTK CYTOKINETICS INC | CA | Oct 20, 2026 | $88.0MFY2025 |
| 991 | SYRE Spyre Therapeutics, Inc. | MA | Oct 9, 2026 | $0FY2025 |
| 1023 | AXSM Axsome Therapeutics, Inc. | NY | Sep 3, 2026 | $638.5MFY2025 |
| 1025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | CA | Aug 20, 2026 | $829.4MFY2025 |
| 1027 | TGTX TG THERAPEUTICS, INC. | NY | Oct 27, 2026 | $616.3MFY2025 |
| 1049 | ABVX Abivax S.A. | — | Sep 21, 2026 | —FY2025 |
| 1075 | ALKS Alkermes plc. | Ireland | Oct 9, 2026 | $1.5BFY2025 |
| 1083 | IONS IONIS PHARMACEUTICALS INC | CA | Oct 23, 2026 | $943.7MFY2025 |
| 1090 | PRAX Praxis Precision Medicines, Inc. | MA | Aug 14, 2026 | $0FY2025 |
| 1101 | AMRX Amneal Pharmaceuticals, Inc. | NJ | Oct 23, 2026 | $3.0BFY2025 |
| 1163 | KNSA Kiniksa Pharmaceuticals International, plc | — | Oct 27, 2026 | $677.6MFY2025 |
| 1178 | RYTM RHYTHM PHARMACEUTICALS, INC. | MA | Oct 13, 2026 | $189.8MFY2025 |
| 1182 | LGND LIGAND PHARMACEUTICALS INC | CA | Oct 6, 2026 | $268.1MFY2025 |
| 1189 | BLTE BELITE BIO, INC | CA | Oct 19, 2026 | —FY2025 |
| 1233 | MANE Veradermics, Inc | CT | Oct 19, 2026 | —FY2025 |
| 1286 | COGT Cogent Biosciences, Inc. | MA | Oct 5, 2026 | —FY2025 |
| 1290 | MIRM Mirum Pharmaceuticals, Inc. | CA | Oct 26, 2026 | $521.3MFY2025 |
| 1295 | ORKA Oruka Therapeutics, Inc. | CA | Oct 26, 2026 | —FY2025 |
| 1307 | PTCT PTC THERAPEUTICS, INC. | NJ | Oct 16, 2026 | $1.7BFY2025 |
| 1332 | GRFS Grifols SA | NY | Jul 30, 2026 | EUR 7.2BFY2024 |
| 1349 | TVTX Travere Therapeutics, Inc. | CA | Oct 19, 2026 | $490.7MFY2025 |
| 1355 | ERAS Erasca, Inc. | CA | Oct 16, 2026 | —FY2025 |
| 1397 | TNGX Tango Therapeutics, Inc. | MA | Oct 23, 2026 | $62.4MFY2025 |
| 1434 | EWTX Edgewise Therapeutics, Inc. | CO | Oct 2, 2026 | —FY2025 |
| 1449 | DNTH Dianthus Therapeutics, Inc. /DE/ | NY | Sep 18, 2026 | $2.0MFY2025 |
| 1486 | INDV Indivior Pharmaceuticals, Inc. | VA | Oct 15, 2026 | $1.2BFY2025 |
| 1501 | ARQT Arcutis Biotherapeutics, Inc. | CA | Oct 20, 2026 | $376.1MFY2025 |
| 1562 | ABCL AbCellera Biologics Inc. | British Columbia, Canada | Aug 24, 2026 | $75.1MFY2025 |
| 1571 | AMLX Amylyx Pharmaceuticals, Inc. | MA | Oct 7, 2026 | $0FY2025 |
| 1573 | LEGN Legend Biotech Corp | NJ | Oct 15, 2026 | $1.0BFY2025 |
| 1581 | OGN Organon & Co. | NJ | Aug 14, 2026 | $6.2BFY2025 |
| 1600 | XENE Xenon Pharmaceuticals Inc. | — | Oct 16, 2026 | $7.5MFY2025 |
| 1603 | LQDA Liquidia Corp | NC | Oct 14, 2026 | $158.3MFY2025 |
| 1604 | ACAD ACADIA PHARMACEUTICALS INC | CA | Oct 23, 2026 | $1.1BFY2025 |
| 1610 | IDYA IDEAYA Biosciences, Inc. | CA | Oct 8, 2026 | $218.7MFY2025 |
| 1649 | VKTX Viking Therapeutics, Inc. | CA | Sep 28, 2026 | $0FY2025 |
| 1661 | TLX Telix Pharmaceuticals Ltd | Australia | Oct 21, 2026 | $803.8MFY2025 |
| 1686 | ELVN Enliven Therapeutics, Inc. | CA | Oct 27, 2026 | —FY2025 |
| 1712 | DYN Dyne Therapeutics, Inc. | MA | Oct 22, 2026 | —FY2025 |
| 1724 | IRON Disc Medicine, Inc. | MA | Oct 26, 2026 | —FY2025 |
| 1762 | NRIX Nurix Therapeutics, Inc. | CA | Oct 15, 2026 | $84.0MFY2025 |
| 1797 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | CA | Oct 9, 2026 | $185.7MFY2025 |
| 1798 | VRDN Viridian Therapeutics, Inc.\DE | MA | Aug 20, 2026 | $70.8MFY2025 |
| 1814 | NAMS NewAmsterdam Pharma Co N.V. | Netherlands | Oct 2, 2026 | $22.5MFY2025 |
| 1830 | HCM HUTCHMED (China) Ltd | — | Oct 27, 2026 | $548.5MFY2025 |
| 1832 | ZLAB Zai Lab Ltd | — | Oct 23, 2026 | $460.2MFY2025 |
| 1834 | MBX MBX Biosciences, Inc. | IN | Oct 22, 2026 | —FY2025 |
| 1847 | RCUS Arcus Biosciences, Inc. | CA | Oct 23, 2026 | $247.0MFY2025 |
| 1849 | BHC Bausch Health Companies Inc. | Quebec, Canada | Oct 2, 2026 | $10.3BFY2025 |
| 1853 | SUPN SUPERNUS PHARMACEUTICALS, INC. | MD | Oct 26, 2026 | $719.0MFY2025 |
| 1866 | PBH Prestige Consumer Healthcare Inc. | NY | Aug 14, 2026 | $1.1BFY2026 |
| 1879 | AUPH Aurinia Pharmaceuticals Inc. | Alberta, Canada | Sep 11, 2026 | $283.1MFY2025 |
| 1883 | PGEN PRECIGEN, INC. | MD | Sep 24, 2026 | $9.7MFY2025 |
| 1884 | SLS SELLAS Life Sciences Group, Inc. | NY | Oct 27, 2026 | —FY2025 |
| 1888 | PRGO PERRIGO Co plc | Ireland | Sep 15, 2026 | $4.3BFY2025 |
| 1892 | HRMY Harmony Biosciences Holdings, Inc. | PA | Oct 27, 2026 | $868.5MFY2025 |
| 1896 | AGIO AGIOS PHARMACEUTICALS, INC. | MA | Oct 26, 2026 | $54.0MFY2025 |
| 1900 | BHVN Biohaven Ltd. | CT | Oct 22, 2026 | —FY2025 |
| 1918 | PHVS Pharvaris N.V. | — | Oct 13, 2026 | —FY2025 |
| 1933 | IMNM Immunome Inc. | WA | Oct 5, 2026 | $6.9MFY2025 |
| 1944 | VERA Vera Therapeutics, Inc. | CA | Sep 17, 2026 | —FY2025 |
| 1956 | LKFT Lakefront Biotherapeutics NV | — | Oct 20, 2026 | EUR 1.1BFY2025 |
| 1968 | ZYME Zymeworks Inc. | DE | Oct 26, 2026 | $106.0MFY2025 |
| 1992 | XERS Xeris Biopharma Holdings, Inc. | IL | Oct 14, 2026 | $291.8MFY2025 |
| 2011 | SRPT Sarepta Therapeutics, Inc. | MA | Sep 23, 2026 | $2.2BFY2025 |
| 2021 | XNCR Xencor Inc | CA | Oct 27, 2026 | $125.6MFY2025 |
| 2023 | SEPN Septerna, Inc. | CA | Oct 19, 2026 | $46.0MFY2025 |
| 2036 | MLYS Mineralys Therapeutics, Inc. | PA | Oct 20, 2026 | —FY2025 |
| 2039 | ZBIO Zenas BioPharma, Inc. | MA | Oct 27, 2026 | $10.0MFY2025 |
| 2044 | TRVI Trevi Therapeutics, Inc. | CT | Oct 27, 2026 | —FY2025 |
| 2045 | PVLA PALVELLA THERAPEUTICS, INC. | PA | Oct 23, 2026 | —FY2025 |
| 2087 | URGN UroGen Pharma Ltd. | Israel | Oct 27, 2026 | $109.8MFY2025 |
| 2092 | ANIP ANI PHARMACEUTICALS INC | NJ | Oct 16, 2026 | $883.4MFY2025 |
| 2105 | SDGR Schrodinger, Inc. | NY | Sep 21, 2026 | $255.9MFY2025 |
| 2109 | STOK Stoke Therapeutics, Inc. | MA | Oct 21, 2026 | $184.4MFY2025 |
| 2110 | NUVB Nuvation Bio Inc. | NY | Aug 21, 2026 | $62.9MFY2025 |
| 2134 | PAHC PHIBRO ANIMAL HEALTH CORP | NJ | Oct 19, 2026 | $1.5BFY2026 |
| 2138 | QURE uniQure N.V. | — | Oct 16, 2026 | $16.1MFY2025 |
| 2141 | CMPS COMPASS Pathways plc | United Kingdom | Aug 10, 2026 | —FY2025 |
| 2148 | RARE Ultragenyx Pharmaceutical Inc. | CA | Oct 20, 2026 | $673.0MFY2025 |
| 2150 | GPCR Structure Therapeutics Inc. | CA | Sep 22, 2026 | —FY2025 |
| 2166 | INVA Innoviva, Inc. | CA | Oct 27, 2026 | $411.3MFY2025 |
| 2170 | KRSA Korsana Biosciences, Inc. | MA | Oct 22, 2026 | $2.1MFY2025 |
| 2182 | NBTX Nanobiotix S.A. | France | Oct 26, 2026 | EUR 32.6MFY2025 |
| 2197 | PCRX Pacira BioSciences, Inc. | CA | Oct 13, 2026 | $726.4MFY2025 |
| 2200 | OCUL OCULAR THERAPEUTIX, INC | MA | Oct 16, 2026 | $52.0MFY2025 |
| 2203 | ANAB ANAPTYSBIO, INC | CA | Oct 2, 2026 | $234.6MFY2025 |
| 2205 | TYRA Tyra Biosciences, Inc. | CA | Oct 27, 2026 | —FY2025 |
| 2208 | ETON Eton Pharmaceuticals, Inc. | IL | Oct 14, 2026 | $80.0MFY2025 |
| 2215 | ORIC Oric Pharmaceuticals, Inc. | CA | Oct 23, 2026 | —FY2025 |
| 2216 | AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL | — | Oct 22, 2026 | CNY 980.6MFY2024 |
| 2250 | DMRA Damora Therapeutics, Inc. | MA | Sep 28, 2026 | —FY2025 |
| 2264 | NKTR NEKTAR THERAPEUTICS | CA | Oct 20, 2026 | $55.2MFY2025 |
| 2268 | GHRS GH Research PLC | Ireland | Oct 9, 2026 | —FY2025 |
| 2276 | LBRX LB PHARMACEUTICALS INC | NY | Oct 13, 2026 | —FY2025 |
| 2286 | RAPP Rapport Therapeutics, Inc. | MA | Oct 27, 2026 | —FY2025 |
| 2294 | OPK OPKO HEALTH, INC. | FL | Oct 15, 2026 | $606.9MFY2025 |
| 2301 | SLN Silence Therapeutics plc | — | Oct 19, 2026 | $559.0KFY2025 |
| 2315 | OMER OMEROS CORP | WA | Sep 24, 2026 | —FY2025 |
| 2317 | SNDX Syndax Pharmaceuticals Inc | NY | Aug 7, 2026 | $172.4MFY2025 |
| 2336 | BCAX Bicara Therapeutics Inc. | MA | Oct 21, 2026 | —FY2025 |
| 2369 | AMPH Amphastar Pharmaceuticals, Inc. | CA | Sep 23, 2026 | $719.9MFY2025 |
| 2387 | MLTX MoonLake Immunotherapeutics | Switzerland | Sep 30, 2026 | —FY2025 |
| 2398 | HROW HARROW, INC. | TN | Oct 27, 2026 | $272.3MFY2025 |
| 2412 | JANX Janux Therapeutics, Inc. | CA | Aug 14, 2026 | $10.0MFY2025 |
| 2418 | MNKD MANNKIND CORP | CT | Sep 28, 2026 | $349.0MFY2025 |
| 2457 | JBIO Jade Biosciences, Inc. | MA | Oct 27, 2026 | —FY2025 |
| 2469 | AVBP ArriVent BioPharma, Inc. | PA | Oct 26, 2026 | —FY2025 |
| 2479 | AKTS Aktis Oncology, Inc. | MA | Sep 24, 2026 | — |
| 2482 | SVRA Savara Inc | TX | Sep 25, 2026 | —FY2025 |
| 2490 | RIGL RIGEL PHARMACEUTICALS INC | CA | Sep 3, 2026 | $294.3MFY2025 |
| 2495 | CYRX Cryoport, Inc. | TN | Aug 14, 2026 | $176.2MFY2025 |
| 2501 | VSTM Verastem, Inc. | MA | Oct 14, 2026 | $30.9MFY2025 |
| 2508 | ANRO Alto Neuroscience, Inc. | CA | Oct 5, 2026 | —FY2025 |
| 2509 | KURA Kura Oncology, Inc. | CA | Oct 27, 2026 | $67.5MFY2025 |
| 2510 | ALMS ALUMIS INC. | CA | Sep 9, 2026 | $24.1MFY2025 |
| 2515 | CRVS Corvus Pharmaceuticals, Inc. | CA | Aug 7, 2026 | —FY2025 |
| 2532 | IVA Inventiva S.A. | France | Oct 27, 2026 | EUR 9.2MFY2024 |
| 2548 | ARDX ARDELYX, INC. | CA | Aug 25, 2026 | $407.3MFY2025 |
| 2598 | COLL COLLEGIUM PHARMACEUTICAL, INC | MA | Oct 19, 2026 | $780.6MFY2025 |
| 2599 | HELP Helus Pharma Inc. | — | Oct 27, 2026 | —FY2025 |
| 2614 | PHAR Pharming Group N.V. | Netherlands | Oct 27, 2026 | $376.1MFY2025 |
| 2627 | GERN GERON CORP | CA | Oct 1, 2026 | —FY2025 |
| 2639 | ANNX Annexon, Inc. | CA | Sep 25, 2026 | —FY2025 |
| 2680 | SGMT Sagimet Biosciences Inc. | CA | Oct 22, 2026 | —FY2025 |
| 2682 | ANL Adlai Nortye Group Ltd. | — | Oct 15, 2026 | —FY2024 |
| 2688 | IMMX Immix Biopharma, Inc. | CA | Oct 27, 2026 | —FY2025 |
| 2694 | NVCT Nuvectis Pharma, Inc. | NJ | Aug 28, 2026 | —FY2025 |
| 2703 | LXRX LEXICON PHARMACEUTICALS, INC. | TX | Aug 14, 2026 | $49.8MFY2025 |
| 2725 | WVE Wave Life Sciences, Inc. | MA | Oct 27, 2026 | $42.7MFY2025 |
| 2732 | DSGN Design Therapeutics, Inc. | CA | Aug 14, 2026 | $0FY2025 |
| 2744 | ABUS Arbutus Biopharma Corp | PA | Oct 27, 2026 | $14.1MFY2025 |
| 2758 | CRMD CorMedix Inc. | NJ | Oct 19, 2026 | $311.7MFY2025 |
| 2765 | GYRE GYRE THERAPEUTICS, INC. | CA | Oct 22, 2026 | $116.6MFY2025 |
| 2770 | ZVRA ZEVRA THERAPEUTICS, INC. | MA | Oct 13, 2026 | $106.5MFY2025 |
| 2777 | CLYM Climb Bio, Inc. | MA | Oct 27, 2026 | —FY2025 |
| 2789 | OLMA Olema Pharmaceuticals, Inc. | CA | Oct 16, 2026 | —FY2025 |
| 2806 | IRWD IRONWOOD PHARMACEUTICALS INC | MA | Oct 16, 2026 | $296.2MFY2025 |
| 2815 | PBYI PUMA BIOTECHNOLOGY, INC. | CA | Oct 6, 2026 | $228.4MFY2025 |
| 2822 | PHAT Phathom Pharmaceuticals, Inc. | NJ | Oct 26, 2026 | $175.1MFY2025 |
| 2827 | ACRS Aclaris Therapeutics, Inc. | PA | Oct 27, 2026 | $7.8MFY2025 |
| 2838 | STTK Shattuck Labs, Inc. | TX | Oct 27, 2026 | $1.0MFY2025 |
| 2848 | EVO Evotec SE | — | Oct 15, 2026 | EUR 797.0MFY2024 |
| 2869 | FTH Faeth Therapeutics, Inc. | TX | Oct 27, 2026 | —FY2025 |
| 2874 | CTMX CytomX Therapeutics, Inc. | CA | Oct 16, 2026 | $76.2MFY2025 |
| 2885 | DRUG BRIGHT MINDS BIOSCIENCES INC. | IL | Oct 2, 2026 | —FY2024 |
| 2889 | AQST Aquestive Therapeutics, Inc. | NJ | Oct 23, 2026 | $44.5MFY2025 |
| 2900 | EPRX EUPRAXIA PHARMACEUTICALS INC. | — | Oct 22, 2026 | $0FY2025 |
| 2908 | OCS Oculis Holding AG | Switzerland | Sep 30, 2026 | —FY2025 |
| 2909 | EOLS Evolus, Inc. | CA | Sep 4, 2026 | $297.2MFY2025 |
| 2911 | ARVN ARVINAS, INC. | CT | Sep 28, 2026 | $262.6MFY2025 |
| 2923 | NGNE Neurogene Inc. | NY | Oct 7, 2026 | $0FY2025 |
| 2925 | CBIO CRESCENT BIOPHARMA, INC. | MA | Oct 27, 2026 | $10.8MFY2025 |
| 2929 | MNPR Monopar Therapeutics | IL | Oct 27, 2026 | $0FY2025 |
| 2955 | DMAC DiaMedica Therapeutics Inc. | MN | Aug 12, 2026 | —FY2025 |
| 2960 | OVID Ovid Therapeutics Inc. | NY | Aug 24, 2026 | $7.3MFY2025 |
| 2974 | MPLT MapLight Therapeutics, Inc. | CA | Oct 16, 2026 | —FY2025 |
| 2984 | KMDA KAMADA LTD | Israel | Oct 6, 2026 | $180.5MFY2025 |
| 2986 | VREOF Vireo Growth Inc. | MN | Oct 22, 2026 | $268.8MFY2025 |
Ranked by position in the SEC company ticker list (roughly by market value) among all companies we track. Revenue is the latest full fiscal year; amounts in a foreign currency are shown with its code.
Advertisement
Latest reports from these companies
Annual, quarterly and current reports and proxy statements filed by the companies above, newest first.
| Filed | Company | Form | What it is | Original |
|---|---|---|---|---|
| Oct 27, 2026 | ACRS Aclaris Therapeutics, Inc. | 8-K | Material agreement· period Oct 27, 2026 | Document · Index |
| Oct 27, 2026 | ACRS Aclaris Therapeutics, Inc. | 8-K | Results of operations; Regulation FD disclosure; Other events· period Oct 27, 2026 | Document · Index |
| Oct 27, 2026 | AZN ASTRAZENECA PLC | 6-K | ENHERTU APPROVED IN EU FOR HER2-POSITIVE EBC· period Oct 27, 2026 | Document · Index |
| Oct 27, 2026 | FTH Faeth Therapeutics, Inc. | 8-K | Director or officer change· period Oct 23, 2026 | Document · Index |
| Oct 27, 2026 | HCM HUTCHMED (China) Ltd | 6-K | Report of a foreign private issuer· period Oct 27, 2026 | Document · Index |
| Oct 27, 2026 | HELP Helus Pharma Inc. | 6-K | Report of a foreign private issuer· period Oct 27, 2026 | Document · Index |
| Oct 27, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | 8-K | Results of operations· period Oct 27, 2026 | Document · Index |
| Oct 27, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | 10-Q | Quarterly report· period Sep 30, 2026 | Document · Index |
| Oct 27, 2026 | NVS NOVARTIS AG | 6-K | Report of a foreign private issuer· period Sep 30, 2026 | Document · Index |
| Oct 27, 2026 | PHAR Pharming Group N.V. | 6-K | Report of a foreign private issuer· period Oct 27, 2026 | Document · Index |
| Oct 27, 2026 | WVE Wave Life Sciences, Inc. | 10-Q | Quarterly report· period Sep 30, 2026 | Document · Index |
| Oct 27, 2026 | WVE Wave Life Sciences, Inc. | 8-K | Results of operations· period Oct 27, 2026 | Document · Index |
| Oct 26, 2026 | ASND Ascendis Pharma A/S | 6-K | Report of a foreign private issuer· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | AVBP ArriVent BioPharma, Inc. | 8-K | Regulation FD disclosure; Other events· period Oct 25, 2026 | Document · Index |
| Oct 26, 2026 | CLYM Climb Bio, Inc. | 8-K | Regulation FD disclosure; Other events· period Oct 24, 2026 | Document · Index |
| Oct 26, 2026 | GSK GSK plc | 6-K | RIS-REZ POSITIVE PH 3 OSTEOSARCOMA DATA IN CHINA· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | GSK GSK plc | 6-K | DIRECTOR/PDMR SHAREHOLDING· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | GSK GSK plc | 6-K | JEMPERLI DATA SHOW 76% COMPLETE RESPONSE RATE· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | GSK GSK plc | 6-K | POSITIVE MO-REZ PHASE IB DATA IN OVARIAN CANCER· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | HCM HUTCHMED (China) Ltd | 6-K | Report of a foreign private issuer· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | JAZZ Jazz Pharmaceuticals plc | 8-K | Results of operations· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | MIRM Mirum Pharmaceuticals, Inc. | 8-K | Other events· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | NBTX Nanobiotix S.A. | 6-K | Report of a foreign private issuer· period Oct 24, 2026 | Document · Index |
| Oct 26, 2026 | NVO NOVO NORDISK A S | 6-K | Report of a foreign private issuer· period Oct 26, 2026 | Document · Index |
| Oct 26, 2026 | ORKA Oruka Therapeutics, Inc. | 8-K | Regulation FD disclosure; Other events· period Oct 26, 2026 | Document · Index |
Related industries in Manufacturing
- Semiconductors & Related Devices (71)
- Biological Products, (No Diagnostic Substances) (61)
- Surgical & Medical Instruments & Apparatus (51)
- Motor Vehicle Parts & Accessories (21)
- Motor Vehicles & Passenger Car Bodies (17)
- Petroleum Refining (17)
- Miscellaneous Electrical Machinery, Equipment & Supplies (15)
- Radio & Tv Broadcasting & Communications Equipment (13)
- Laboratory Analytical Instruments (12)
- Beverages (11)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (11)
- Steel Works, Blast Furnaces & Rolling Mills (Coke Ovens) (11)
Source
- U.S. Securities and Exchange Commission, EDGAR company submissions (SIC code and description) and XBRL company facts. The SEC does not endorse OpenFilings.
Advertisement